(Q46814570)

25 December 2017

title

Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress (English)

1 reference

25 December 2017

author name string

Escobales N

series ordinal

1

1 reference

25 December 2017

Crespo MJ

series ordinal

2

1 reference

25 December 2017

publication date

21 November 2005

1 reference

25 December 2017

published in

Vascular Pharmacology

1 reference

25 December 2017

volume

44

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

22-28

1 reference

25 December 2017

Stress pathways and heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Altered vascular function in early stages of heart failure in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Endothelial dysfunction in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Oxidative-nitrosative stress in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Myocardial contractility in relation to hypertrophy and failure in myopathic Syrian hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Isoproterenol-induced cardiac necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Abnormal intracellular calcium handling in acute and chronic heart failure: role in systolic and diastolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Transthoracic echocardiography in models of cardiac disease in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

The dysfunctional endothelium in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Endothelin in human congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

Cardiomyopathic Syrian hamster: a possible model of human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.09.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2005.09.008

1 reference

25 December 2017

1 reference

25 December 2017